(Q79805351)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Scott S Tykodi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

John A Thompson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1947-1953

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients.

26 December 2019

cites work

1 reference

12 December 2020

Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells

1 reference

12 December 2020

Identification and functional validation of MHC class I epitopes in the tumor-associated antigen 5T4.

1 reference

12 December 2020

5T4 oncofetal antigen expression in ovarian carcinoma

1 reference

12 December 2020

Spontaneous regression of cancer

1 reference

12 December 2020

Immunohistological distribution of 5T4 antigen in normal and malignant tissues

1 reference

12 December 2020

Natural T cell immunity against cancer.

1 reference

12 December 2020

5T4 oncofetal antigen in gastric carcinoma and its clinical significance

1 reference

12 December 2020

Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors

1 reference

12 December 2020

A 72 kD trophoblast glycoprotein defined by a monoclonal antibody

1 reference

12 December 2020

Cancer immunotherapy: moving beyond current vaccines

1 reference

12 December 2020

Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients

1 reference

12 December 2020

Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses.

1 reference

12 December 2020

Vaccination of prostate cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax): a phase 2 trial

1 reference

12 December 2020

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

1 reference

12 December 2020

The expression of 5T4 antigen in colorectal and gastric carcinoma

1 reference

12 December 2020

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

12 December 2020

Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma

1 reference

12 December 2020

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

1 reference

12 December 2020

Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial

1 reference

12 December 2020

Investigation of expression of 5T4 antigen in cervical cancer

1 reference

12 December 2020

Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4+ T cell dependent and antibody mediated

1 reference

12 December 2020

Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy

1 reference

12 December 2020

A leucine-rich repeat membrane protein, 5T4, is expressed by a subtype of granule cells with dendritic arbors in specific strata of the mouse olfactory bulb.

1 reference

12 December 2020

Cancer vaccines: moving beyond current paradigms

1 reference

12 December 2020

Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

1 reference

12 December 2020

Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4.

1 reference

12 December 2020

Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer

1 reference

12 December 2020

Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats.

1 reference

12 December 2020

The pattern of expression of the 5T4 oncofoetal antigen on normal, dysplastic and malignant oral mucosa

1 reference

12 December 2020

Oncofetal antigen 5T4 expression as a prognostic factor in patients with gastric cancer

1 reference

12 December 2020

Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses

1 reference

12 December 2020

10.1517/14712590802567298

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18990081%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

18990081

1 reference